Please login to the form below

Not currently logged in
Email:
Password:

Merck expands in emerging markets

Merck has acquired a supplier to the biopharma industry in China as it opens a new technology centre in India

Merck has announced the acquisition of Beijing Skywing Technology, a supplier of cell-culture media products, technical services and bioreactors for the Chinese biopharmaceutical industry.

The deal, worth around €14m, will see German-based Merck take 100 per cent share of the company adding to its presence in China where it currently employs 600 people. The company said it expects the country's biopharmaceutical market to grow by 20 per cent over the next few years.

"The acquisition allows Merck to immediately establish a direct presence in this market segment in China with access to an attractive and innovative cell-culture media portfolio, close relationships to local customers, a skilled management team and a high-quality facility," said Burghard Freiberg, head of the business field pharma chemicals solutions of the Merck Millipore division.

Dr Matthias Bucerius, head of sales Asia, pharma chemicals solutions of the Merck Millipore division, said: "Beijing Skywing Technology is one of the leading players in the cell-culture media market in China with very close business relationships to vaccine manufacturers and an excellent reputation in the local biotech industry."

In addition to this acquisition, Merck also opened a new technology centre in Mumbai, India focusing on research services in both pharmaceuticals and biotechnology. The centre comprises eight laboratories, with the discovery of new biological and chemical entities for use in drug development a key area of research.

Speaking on the opening of the centre, Klaus Bischoff, head of laboratory solutions business unit, Merck Millipore, said: "Supported by over 300 years of experience, the new application and technology centre will be an ideal platform to showcase Merck's capabilities in the high growth fields of biopharmaceutical process solutions and laboratory essentials as well as pigments and cosmetics for our customers in India."

5th January 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...